Elevated expression of TAGLN2 has been reported in multiple malignancies, including colorectal cancer (13), bladder cancer (14), lung cancer (15), cervical squamous cell carcinoma (16), and breast cancer (17). Here, TAGLN2 is linked to colorectal cancer.